Tetrahydrocarbazole derivatives and their pharmaceutical use

Details Tetrahydrocarbazole derivatives and their pharmaceutical use Tetrahydrocarbazole derivatives and their pharmaceutical use

2008-09-02

2008-09-02

Anderson, Rebecca L (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S406000, C514S397000, C514S339000, C548S439000, C548S311400, C548S364700

Reexamination Certificate

active

10560016

ABSTRACT:
The present invention relates to novel compounds that are useful in the treatment of human papillomaviruses, and also to the methods for the making and use of such compounds.

REFERENCES:
patent: 2003/0232873 (2003-12-01), Koppitz et al.
patent: 0 451 634 (1991-10-01), None
patent: 0 496 314 (1992-07-01), None
patent: 02/00632 (2002-01-01), None
Bernard, H. (J. of Antimicrobial Chemotherapy 2004, 53, 137-139).
Eash et al. (Cell. Mol. Life. Sci. 2006, 63, 865-876).
A. Bailey, “Further examination of the reactions between arenesulphonyl azides and tetrahydrocarbazoles,”Journal of the Chemical Society, Perkin Trans I, V17, 1973, pp. 1809-1818.
Database Chemcats Chemical Abstract Service, Columbus, OH, XP002300241 order Nos. 5781459 and 5781444.
“Chembridge screening library”, May 19, 2004, Chembridge Corporation, 16981 Via Tazon, Suite G, San Diego, CA 92127.

Affiliated with

Also associated with

Rating

Tetrahydrocarbazole derivatives and their pharmaceutical use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tetrahydrocarbazole derivatives and their pharmaceutical use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetrahydrocarbazole derivatives and their pharmaceutical use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3909512